Our results in humans with suspected NAFLD partly corroborate this hypothesis, highlighting complex interactions between FLI, ALP, AAA-1 and FRS, and even suggest that the previously reported link between AAA-1 and CVD could be influenced by the degree of liver steatosis. The gene discussed is FLII; the disease is metabolic dysfunction-associated steatotic liver disease.